Otsuka and Lundbeck's Statement on FDA Advisory Committee Meeting for REXULTI in Alzheimer's Agitation

Otsuka Pharmaceutical Development & Commercialization, Inc., (Otsuka) and Lundbeck Pharmaceuticals LLC (Lundbeck) announce the Joint Meeting of the Psy...

April 18, 2023 | Tuesday | News
Avenue Therapeutics Announces Regulatory Update Based on Type C Meeting with FDA and Next Steps in the Development of IV Tramadol

As disclosed in September 2022, Avenue received meeting minutes from the FDA regarding a Type A meeting conducted on August 9, 2022, for IV Tramadol. At th...

April 18, 2023 | Tuesday | News
Experience Asia's Leading Biotech Event: BIO Asia-Taiwan 2023

Asia’s largest bioindustry-focused gathering, BIO Asia–Taiwan 2023, will be held July 26th to 30th, 2023, in Taipei, Taiwan. Co-organized by BI...

April 18, 2023 | Tuesday | News
Scientists from Singapore & Sweden makes progress in restoring vision lost to cellular degeneration

 A preclinical study using stem cells to produce progenitor photoreceptor cells—light-detecting cells found in the eye—and then transplant...

April 17, 2023 | Monday | News
TORL BioTherapeutics Launches with $158M to Develop Novel Oncology Biologics

Co-founded by acclaimed oncologist Dennis Slamon, M.D., Ph.D., of University of California at Los Angeles (UCLA) and entrepreneur and CEO David Licata, a...

April 17, 2023 | Monday | News
Caris Life Sciences and Flare Therapeutics Form Partnership for Precision Oncology Pipeline

The partnership reinforces Flare's commitment to longitudinal testing, leveraging Caris' comprehensive molecular tissue and liquid profiling services inclu...

April 17, 2023 | Monday | News
Agena Bioscience and nRichDX Partner for Liquid Biopsy Analyte Extraction and Detection Solutions

Agena Bioscience and nRichDX have advanced their existing technical collaboration to a commercial partnership that co-promotes their products to researcher...

April 17, 2023 | Monday | News
QIAGEN showcases latest technologies to advance cancer research at AACR Annual Meeting 2023

QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced the launch of QIAseq Targeted cfDNA Ultra Panels that will enable researchers studying cancer ...

April 17, 2023 | Monday | News
Merck Strengthens Immunology Pipeline with Acquisition of Prometheus Biosciences, Inc.

PRA023 is a novel, late-stage candidate for ulcerative colitis and Crohn’s disease and other autoimmune conditions   Prometheus Biosciences&rs...

April 17, 2023 | Monday | News
Daon to Bring Trusted Identity Proofing and Authentication Solutions to Healthcare Industry

Daon, the Digital Identity Trust company, is expanding its identity proofing and authentication solutions to the healthcare industry to enable organization...

April 14, 2023 | Friday | News
Merck invests in largest specialty gases facility in Hometown, PA.

Agreement with the Commonwealth of Pennsylvania supports expansion of manufacturing capacities for the semiconductor industry The roughly € 300 mil...

April 14, 2023 | Friday | News
Initiation of New Patients on Evobrutinib Paused in the U.S.; Fully Enrolled Phase III Evobrutinib Studies Continue

Merck, a leading science and technology company, today announced the U.S. Food and Drug Administration (FDA) has placed a partial clinical hold on the init...

April 14, 2023 | Friday | News
Aspect Biosystems, Novo Nordisk partner to bioprint tissue therapies for diabetes, obesity.

Partnership will leverage Aspect’s proprietary bioprinting technology and Novo Nordisk’s expertise and technology in stem cell differentiation ...

April 14, 2023 | Friday | News
U.S. Food and Drug Administration Issues Complete Response Letter for Mirikizumab

"We remain confident in mirikizumab's pivotal Phase 3 clinical data and its potential to help people with ulcerative colitis," said Patrik Jonsson, Lilly e...

April 14, 2023 | Friday | Regulatory

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close